Marinus Pharmaceuticals, Inc (MRNS) with an increase of 61%; revealed outstanding results from its registrational stage 3 clinical trial (Marigold Study) estimating the use of oral ganaxolone in children and young adults with CDKL5 deficiency disorder (CDD) a rare, genetic epilepsy.

Nikola (NKLA) with a decrease of 7%; The SEC is inspecting Nikola to evaluate the merits of short seller Hindenburg’s declarations that the corporation misled investors  over its business prospects, according to Bloomberg, citing people familiar with the situation. 

PPD, Inc (PPD) with a decrease of 4.6%; revealed that specific stockholders of the corporation, including stockholders associated with Hellman & Friedman LLC and The Carlyle Group Inc,. have initiated an underwritten public offering of 38,000,000 shares of the corporations common stock pursuant to a registration statement filled with the Securities and Exchange Commision. 

Forterra, Inc (FRTA) with a decrease of 4.2%; revealed today that the Corporation’s biggest stockholder, an associate of Lone Star Funds, plans to offer for sale an underwritten secondary offering 10,000,000 shares of common stock of the Corporation.